CKM
Basic information
Region (hg38): 19:45306413-45322875
Previous symbols: [ "CKMM" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CKM gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 35 | 36 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 35 | 2 | 1 |
Variants in CKM
This is a list of pathogenic ClinVar variants found in the CKM region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-45306752-A-G | Likely benign (Dec 31, 2019) | |||
19-45306774-G-T | not specified | Uncertain significance (Aug 28, 2023) | ||
19-45306806-C-G | not specified | Uncertain significance (Oct 06, 2021) | ||
19-45306817-A-G | not specified | Uncertain significance (Nov 25, 2024) | ||
19-45306829-C-T | not specified | Uncertain significance (Nov 10, 2021) | ||
19-45306889-A-G | not specified | Uncertain significance (Feb 01, 2023) | ||
19-45306899-C-A | not specified | Uncertain significance (May 26, 2024) | ||
19-45306923-C-T | not specified | Uncertain significance (Oct 12, 2024) | ||
19-45307487-C-A | not specified | Uncertain significance (Nov 26, 2024) | ||
19-45307488-G-A | not specified | Uncertain significance (Oct 07, 2024) | ||
19-45307602-G-A | not specified | Uncertain significance (Aug 19, 2024) | ||
19-45307628-G-A | not specified | Uncertain significance (Dec 22, 2023) | ||
19-45307628-G-T | not specified | Uncertain significance (Jul 25, 2023) | ||
19-45308434-C-G | Likely benign (Mar 01, 2023) | |||
19-45308455-C-T | not specified | Uncertain significance (Jan 18, 2022) | ||
19-45311752-A-T | not specified | Uncertain significance (May 17, 2023) | ||
19-45311758-C-T | not specified | Uncertain significance (Dec 12, 2023) | ||
19-45311776-C-T | not specified | Uncertain significance (Aug 17, 2022) | ||
19-45311819-C-T | not specified | Uncertain significance (Aug 26, 2024) | ||
19-45311912-T-C | not specified | Uncertain significance (Jun 21, 2021) | ||
19-45315477-G-A | not specified | Uncertain significance (Sep 14, 2023) | ||
19-45315491-C-T | not specified | Uncertain significance (Sep 12, 2023) | ||
19-45315503-C-A | not specified | Uncertain significance (Jan 24, 2023) | ||
19-45315525-T-G | not specified | Uncertain significance (May 12, 2024) | ||
19-45315542-C-T | not specified | Uncertain significance (May 09, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CKM | protein_coding | protein_coding | ENST00000221476 | 7 | 16564 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00782 | 0.979 | 125715 | 0 | 33 | 125748 | 0.000131 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.661 | 217 | 246 | 0.881 | 0.0000159 | 2517 |
Missense in Polyphen | 59 | 85.019 | 0.69396 | 875 | ||
Synonymous | 0.110 | 102 | 103 | 0.986 | 0.00000738 | 722 |
Loss of Function | 2.17 | 6 | 15.1 | 0.398 | 6.48e-7 | 185 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000447 | 0.000437 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000119 | 0.000114 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000106 | 0.0000980 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Reversibly catalyzes the transfer of phosphate between ATP and various phosphogens (e.g. creatine phosphate). Creatine kinase isoenzymes play a central role in energy transduction in tissues with large, fluctuating energy demands, such as skeletal muscle, heart, brain and spermatozoa.;
- Pathway
- Arginine and proline metabolism - Homo sapiens (human);Abacavir Pathway, Pharmacokinetics/Pharmacodynamics;Urea cycle and metabolism of amino groups;creatine-phosphate biosynthesis;Metabolism of polyamines;Metabolism of amino acids and derivatives;Metabolism;Arginine Proline metabolism;Regulation of retinoblastoma protein;Creatine metabolism
(Consensus)
Recessive Scores
- pRec
- 0.795
Intolerance Scores
- loftool
- 0.637
- rvis_EVS
- -0.11
- rvis_percentile_EVS
- 45.36
Haploinsufficiency Scores
- pHI
- 0.294
- hipred
- N
- hipred_score
- 0.439
- ghis
- 0.505
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.998
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ckm
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); homeostasis/metabolism phenotype; growth/size/body region phenotype; muscle phenotype; cellular phenotype;
Gene ontology
- Biological process
- creatine metabolic process;phosphorylation;phosphocreatine biosynthetic process
- Cellular component
- extracellular space;cytosol
- Molecular function
- creatine kinase activity;protein binding;ATP binding